Skip to content
Peptigraph home

BPC-157 and KPV Together: What Is Known

BPC-157 and KPV taken together: what each one is, how each is regulated, and what is known about combining them.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated
Gastric pentadecapeptidePCAC voted 8–6 for 503A (Jul 2026)BPC-157BPC-157, an experimental gastric pentadecapeptide, not an approved drug; human evidence is a few small uncontrolled reports, including complete symptom resolution in 10 of 12 patients in a bladder pilot.[7]Healing & recoveryAnti-inflammatory tripeptidePCAC voted 8–6 for 503A (Jul 2026)KPVAnti-inflammatory tripeptide fragment of alpha-MSH; evidence is animal and cell studies only, such as earlier recovery in a mouse colitis model.[9]Healing & recovery
Interaction notes

Timing, interactions and safety

Evidence for the combination

No studies tested these together (PubMed search: 1 result, 2 Oct 2026).

Neither is FDA approved for use in people, and we have no sourced data on combining them.
Each component

Side by side

Showing 9 of 12 fields where the two differ. Category, FDA status, PCAC vote, Jul 2026 are the same or both unknown.

FieldBPC-157KPV
ClassGastric pentadecapeptideAnti-inflammatory tripeptide
Also calledBPC, body protection compound, Pentadecapeptide BPC 157Lys-Pro-Val, alpha-MSH fragment
WADAProhibited by WADA (S0)BPC-157 is named in S0 (non-approved substances), prohibited at all times, in and out of competition.WADA status unclearKPV: This is not named on the 2026 list. The catch-all class S0 prohibits any drug with no approval anywhere for human use, so it would be banned if no health authority has approved it, but we have not verified that for this substance.
Anti-doping detection
  • A 2023 method detects BPC-157 and five main metabolites in human urine at very low concentrations.PMID 37959764
  • A 2017 anti-doping lab method detects BPC 157 in urine; the peptide was stable in urine for at least 4 days.PMID 28035768
None reportedanti-doping literature, as of 2 Oct 2026
Half-lifeless than 30 minIV and IM (single and repeated) (rat, beagle dog) · Frontiers in pharmacology 2022, PMID 36588717No published half-life foundPubMed search, 11 Oct 2026
Evidence strengthHuman observational evidence, 3 of 4Strongest: Alternative therapies in health and medicine 2025, PMID 40131143Animal evidence, 2 of 4Strongest: Inflammatory bowel diseases 2008, PMID 18092346
Human studies we summarised3 human (0 randomized or controlled) of 25 summarised0 human (0 randomized or controlled) of 9 summarised
Typical study dosesNot reported in study abstractsPubMed search, 11 Oct 2026
Vial sizes sold2 mg, 5 mg, 10 mg, 20 mg5 mg, 10 mg, 20 mg
Related tools

Sold pre-mixed too

Some vials combine these peptides. The blend calculator shows the dose of each component per draw.

Blend calculator

BPC-157: a handful of clinic reports, mostly rat work

In a retrospective knee-pain chart review, 11 of the 12 patients who received only BPC-157 reported significant improvement.[17]

The review was retrospective: of 17 patients, 16 were contacted by phone to follow up on their knee pain.[17]

An intravenous pilot in 2 healthy adults reported no adverse effects.[6]

KPV: mouse colitis models and cell work

In mice with chemically induced colitis, KPV treatment led to earlier recovery and better weight regain, and it rescued mice lacking a working melanocortin-1 receptor from death. This is animal data.[9]

Cell experiments suggest KPV enters intestinal and immune cells through the PepT1 transporter, and giving it by mouth reduced colitis in mice.[18]

FDA reports that it has found no human exposure data for any drug product containing KPV.[19]

Tested together? No

A PubMed search on 2 Oct 2026 for BPC-157 with KPV matched 1 record.

Calculated from pubmed query ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]); records matched 1; search date 2026-10-02. Formula: records_matched = PubMed count recorded in combinations.json for the query on search_date

That record's abstract says it examines the proposed uses of these peptides, the concerns raised during the review, and the practical implications for compounders. It is not a study of the combination.[20]

Both peptides were on the July 23 agenda of FDA's advisory committee for the 503A bulks list.[21]

Common questions

Can you take BPC-157 and KPV together?

This page cites no study of the pair, and FDA has not identified any human exposure data on drug products containing KPV.[19]

Is KPV the same as BPC-157?

No. KPV is a melanocortin-derived tripeptide, alpha-MSH(11-13); BPC-157 is a different peptide.[9]

Sources

  1. 1FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
  2. 2World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  3. 3Stable Isotope Labeling-Based Nontargeted Strategy for Characterization of the In Vitro Metabolic Profile of a Novel Doping BPC-157 in Doping Control by UHPLC-HRMS.Molecules (Basel, Switzerland) · 2023PMID 37959764Accessed 2 Oct 2026
  4. 4Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H.Drug testing and analysis · 2017PMID 28035768Accessed 2 Oct 2026
  5. 5Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs.Frontiers in pharmacology · 2022PMID 36588717Accessed 2 Oct 2026
  6. 6Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.Alternative therapies in health and medicine · 2025PMID 40131143Accessed 2 Oct 2026
  7. 7Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study.Alternative therapies in health and medicine · 2024PMID 39325560Accessed 2 Oct 2026
  8. 8Effects of BPC-157 and TB-500 on Achilles tendon healing in rats: A histopathological and biomechanical study.Joint diseases and related surgery · 2026PMID 42542926Accessed 2 Oct 2026
  9. 9Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.Inflammatory bowel diseases · 2008PMID 18092346Accessed 2 Oct 2026
  10. 10PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) (132 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (alpha-MSH[tiab] OR melanocortin[tiab] OR colitis[tiab] OR inflammat*[tiab]) (95 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (2 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (clinical trial[pt] OR randomized[tiab] OR patients[tiab]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14PubMed search: ("BPC-157"[tiab] OR BPC157[tiab] OR "body protection compound"[tiab] OR "pentadecapeptide BPC"[tiab]) AND (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  15. 15Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
  16. 16PubMed search: (KPV[tiab] OR "Lys-Pro-Val"[tiab] OR "lysine-proline-valine"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (8 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  17. 17Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.Alternative therapies in health and medicine · 2021PMID 34324435Accessed 2 Oct 2026
  18. 18PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation.Gastroenterology · 2008PMID 18061177Accessed 2 Oct 2026
  19. 19Official web pageOfficial web page · web page
  20. 20Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards.International journal of pharmaceutical compounding · 2026PMID 42752426Accessed 2 Oct 2026
  21. 21Official web pageOfficial web page · web page

Found an error? Report a correction.